Moderna shares fall despite promising data from cancer vaccine trial

Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.

from Health and Science https://ift.tt/YXtTAVH
https://ift.tt/sR7S9B8
https://ift.tt/dyTDxb1